References
- Teerawattanasook N, Limmathurotsakul D, Day Nicholas PJ, Wuthiekanun V. Short Report: Failure of Burkholderia pseudomallei to grow in an automated blood culture system. Am J Trop Med Hyg. 2014; 91: 1173-5.10.4269/ajtmh.14-0018
- Parameswaran U, Baird R, Ward L, Currie B. Melioidosis at the Royal Darwin Hospital in the big 2009-2010 wet season: comparison with the preceding 20 years. Med J Aust. 2012; 196:345-8.22432675
- Currie B, Fisher D, Howard D, Burrow J, Lo D, Selvanayagam S, et al. Endemic melioidosis in tropical Northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis. 2000; 31:981-6.1104978010.1086/318116
- Le Hello S, Currie B, Spratt B, Mikulski M, Lacassin F, Garin B. Melioidosis in New Caledonia. Emerg Infect Dis. 2005; 11:1607-9.1631870610.3201/eid1110.050823
- Currie B, Ward L, Cheng A. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. 2010; 30:e900.
- Currie B, Melioidosis: an Australian perspective of an emerging infectious disease. In: V. Asche (Ed.). Recent Advances in Microbiology. Melbourne: Australia.
- Leelarasamee A. Burkholderia pseudomallei: the unbeatable foe? Southeast Asian J Trop Med Public Health. 1998; 29:410-5.9886137
- Rajchanuvong A, Chaowagul W, Suputtamongkol Y, Smith MD, Dance DAB, White NJ. A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg. 1995; 89:546-9.10.1016/0035-9203(95)90104-38560537
- Chaowagul W, Suputtamongkol Y, Dance DAB, Rajchanuvong A, Pattara-Arechachai J, White NJ. Relapse in melioidosis: incidence and risk factors. J Infect Dis. 1993; 168:1181-5.10.1093/infdis/168.5.11818228352
- Suputtamongkol Y, Dance DAB, Chaowagul W, Wattanagoon Y, Wuthiekanun V, White NJ. Amoxicillinclavulanic acid treatment of melioidosis. Trans R Soc Trop Med Hyg. 1991; 85:672.10.1016/0035-9203(91)90391-B
- Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol. 1995; 49:711-45.856147710.1146/annurev.mi.49.100195.003431
- Vorachit M, Lam K, Jayanetra P, Costerton JW. Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic disc to ceftazidime and cotrimoxazole. Antimicrob Agents Chemother. 1993; 37: 2000-2.10.1128/AAC.37.9.2000
- Sawasdidoln C, Taweechaisupapong S, Sermswan RW, Tattawasart U, Tungpradabkul S, Wongratanacheewin S. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One. 2010; 5:e9196.10.1371/journal.pone.0009196
- Nickel JC, Ruseska I, Wright JB, Costerton JW. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother. 1985; 27:619-24.10.1128/AAC.27.4.619
- Costerton JW, Bacterial biofilms in nature and disease. Ann Rev Microbiol. 1987. 41:435-64.10.1146/annurev.mi.41.100187.002251
- Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284:1318-22.1033498010.1126/science.284.5418.1318
- Lambe DW Jr, Ferguson KP, Mayberry-Carson KJ, Tober-Meyer B, Costerton JW. Foreign-body-associated experimental osteomyelitis induced with Bacteroides fragilis and Staphylococcus epidermidis in rabbits. Clin Orthop Relat Res. 1991; 266:285-94.
- Cochrane DM, Brown MR, Anwar H, Weller PH, Lam K, Costerton JW. Antibody response to Pseudomonas aeruginosa surface protein antigens in a rat model of chronic lung infection. J Med Microbiol. 1988; 27: 255-61.10.1099/00222615-27-4-255
- Khoury A, Lam K, Ellis B, Costerton JW. Prevention and control of bacterial infections associated with medical devices. ASAIO J. 1992; 38:174-8.10.1097/00002480-199207000-00013
- Gillbert P, Das J, Foley I. Biofilm susceptibility to antimicrobials. Adv Dent Res. 1997; 11:160-7.10.1177/089593749701100107019524452
- Ishida H, Ishida Y, Kurosaka Y, Otani T, Sato K, Kobayashi H. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob Agents Chemother.1998; 42: 1641-5.9660997
- Stewart PS. A review of experimental measurements of effective diffusive permeabilities and effective diffusion coefficients in biofilms. Biotechnol Bioeng. 1998; 59:261-72.10.1002/(SICI)1097-0290(19980805)59:3<261::AID-BIT1>3.0.CO;2-910099336
- Brown MR, Allison DG, Gilbert P. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother. 1988; 22:777-80.307233110.1093/jac/22.6.777
- Gilbert P, Collier PJ, Brown MR. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob Agents Chemother. 1990; 34:1865-8.10.1128/AAC.34.10.18652291653
- Vorachit M, Lam K, Jayanetra P, Costerton JW. Study of the pathogenicity of Burkholderia pseudomallei a guinea pig model. J infect Dis Antimicrob Agents. 1995; 12:115-21.
- Taweechaisupapong S, Kaewpa C, Arunyanart C, Kanla P, Homchumpa P. Virulence of Burkholderia pseudomallei does not correlate with biofilm formation. Microb Pathog. 2005; 39:77-85.10.1016/j.micpath.2005.06.00116084684
- Sawasdidoln C, Taweechaisupapong S, Sermswan RW, Tattawasart U, Tungpradabkul S, Wongratanacheewin S. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One. 2010; 5:e9196.10.1371/journal.pone.0009196
- Lee HS, Gu F, Ching SM, Lam Y, Chua KL. CdpA, a Burkholderia pseudomallei cyclic-di-GMP phosphodiesterase involved in autoaggregation, flagella synthesis, motility, biofilm formation, cell invasion and cytotoxicity. Infect immune. 2010; 78: 1832-1840.10.1128/IAI.00446-09
- Korbsrisate S, Vanaporn M, Kerdsuk P, Kespichayawattana W, Vattanaviboon P, Kiatpapan P. et al. The Burkholderia pseudomallei RpoE (AIgU) operon is involved in environmental stress tolerance and biofilm formation. FEMS Microbial Lett. 2005; 252: 243-9.10.1016/j.femsle.2005.09.002
- Puknum A, Tungpradabkul S, Taweechaisupapong S. Proteomic study of Burkholderia pseudomallei wildtype and biofilm defective mutant in biofilm stimulating condition. Poster presentation on Commission on Higher Education Congress III University Staff Development 2010.
- Anuntagool N, Wuthiekanun V, White NJ, Currie BJ, Sermswan RW, Wongratanacheewin S, et al. Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am J Trop Med Hyg. 2006; 74: 348-52.16525090
- Limmathurotsakul D, Paeyao A, Wongratanacheewin S, Saiprom N, Takpho N, Thaipadungpanit J, et al. Role of Burkholderia pseudomallei biofilm formation and lipopolysaccharide in relapse of melioidosis. Clin Microbiol Infect. 2014; 20:O854-6.10.1111/1469-0691.1261424602145
- Soto SM, Smithson A, Horcajada JP, Martinez JA, Mensa JP, Vila J. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect. 2006; 12:1034-6.10.1111/j.1469-0691.2006.01543.x
- Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol. 2007; 5:48-56.10.1038/nrmicro155717143318
- Falagas ME, Kapaskelis AM, Kouranos VD, Kakisi OK, Athanassa Z, Karageorgopoulos DE. Outcome of antimicrobial therapy in documented biofilmassociated infections: a review of the available clinical evidence. Drugs. 2009; 69:1351-61.10.2165/00003495-200969100-00005
- Kamjumphol W, Chareonsudjai S, Chareonsudjai P, Wongratanacheewin S, Taweechaisupapong S. Environmental factors affecting Burkholderia pseudomallei biofilm formation. Southeast Asian J Trop Med Public Health. 2013; 44:72-81.23682440
- Guttenplan SB, Kearns DB. Regulation of flagellar motility during biofilm formation. FEMS Microbiol Rev. 2013; 37:849-71.2348040610.1111/1574-6976.12018
- Tunpiboonsak S, Mongkolrob R, Kitudomsub K, Thanwatanaying P, Kiettipirodom W, Tungboontina Y, et al. Role of a Burkholderia pseudomallei polyphosphate kinase in an oxidative stress response, motilities, and biofilm formation. J Microbiol. 2010; 48: 63-70.10.1007/s12275-010-9138-5
- Gong L, Cullinane M, Treerat P, Ramm G, Prescott M, Adler B, et al. The Burkholderia pseudomallei type III secretion system and BopA are required for evasion of LC3-associated phagocytosis. PLoS One. 2011; 6:e17852.2141243710.1371/journal.pone.0017852
- Eberl L. Quorum sensing in the genus Burkholderia. Int J Med Microbiol. 2006; 296:103-10.10.1016/j.ijmm.2006.01.03516490397